Copper contents(CU) in bodies and serum cerulopasmin(Cp) were assayed in patients with liver cirrhosis(LC) and hepatocarcinoma(HCC) with atomic absorption and other methods. Copper contents(CU) in bodies and serum cerulopasmin(Cp) were assayed in patients with liver cirrhosis(LC) and hepatocarcinoma(HCC) with atomic absorption and other methods.